» Articles » PMID: 33503906

Ibudilast Mitigates Delayed Bone Healing Caused by Lipopolysaccharide by Altering Osteoblast and Osteoclast Activity

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jan 28
PMID 33503906
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Bacterial infection in orthopedic surgery is challenging because cell wall components released after bactericidal treatment can alter osteoblast and osteoclast activity and impair fracture stability. However, the precise effects and mechanisms whereby cell wall components impair bone healing are unclear. In this study, we characterized the effects of lipopolysaccharide (LPS) on bone healing and osteoclast and osteoblast activity in vitro and in vivo and evaluated the effects of ibudilast, an antagonist of toll-like receptor 4 (TLR4), on LPS-induced changes. In particular, micro-computed tomography was used to reconstruct femoral morphology and analyze callus bone content in a femoral defect mouse model. In the sham-treated group, significant bone bridge and cancellous bone formation were observed after surgery, however, LPS treatment delayed bone bridge and cancellous bone formation. LPS inhibited osteogenic factor-induced MC3T3-E1 cell differentiation, alkaline phosphatase (ALP) levels, calcium deposition, and osteopontin secretion and increased the activity of osteoclast-associated molecules, including cathepsin K and tartrate-resistant acid phosphatase in vitro. Finally, ibudilast blocked the LPS-induced inhibition of osteoblast activation and activation of osteoclast in vitro and attenuated LPS-induced delayed callus bone formation in vivo. Our results provide a basis for the development of a novel strategy for the treatment of bone infection.

Citing Articles

Zoledronic Acid Inhibits Lipopolysaccharide-Induced Osteoclastogenesis by Suppressing Macrophage NLRP3-Mediated Autophagy Pathway.

Cheng Y, Liu G, Huang X, Xiong Y, Song N, An Z Immun Inflamm Dis. 2024; 12(12):e70094.

PMID: 39679857 PMC: 11647992. DOI: 10.1002/iid3.70094.


Does Microwave Exposure at Different Doses in the Pre/Postnatal Period Affect Growing Rat Bone Development?.

Karadayi A, Sarsmaz H, Cigel A, Engiz B, Unal N, Urkmez S Physiol Res. 2024; 73(1):157-172.

PMID: 38466013 PMC: 11019611. DOI: 10.33549/physiolres.935148.


The role of autophagy in SIM mediated anti-inflammatory osteoclastogenesis through NLRP3 signaling pathway.

Cheng Y, Jin W, Zheng L, Huang X, Luo S, Hong W Immun Inflamm Dis. 2024; 12(1):e1145.

PMID: 38270300 PMC: 10777745. DOI: 10.1002/iid3.1145.


Cellular and Molecular Mechanisms Associating Obesity to Bone Loss.

Forte Y, Renovato-Martins M, Barja-Fidalgo C Cells. 2023; 12(4).

PMID: 36831188 PMC: 9954309. DOI: 10.3390/cells12040521.


From the Matrix to the Nucleus and Back: Mechanobiology in the Light of Health, Pathologies, and Regeneration of Oral Periodontal Tissues.

Dieterle M, Husari A, Steinberg T, Wang X, Ramminger I, Tomakidi P Biomolecules. 2021; 11(6).

PMID: 34073044 PMC: 8228498. DOI: 10.3390/biom11060824.

References
1.
Tokunaga T, Mokuda S, Kohno H, Yukawa K, Kuranobu T, Oi K . TGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression. Int J Mol Sci. 2020; 21(3). PMC: 7038124. DOI: 10.3390/ijms21030800. View

2.
Chang Y, Hsiao Y, Hu C, Chang C, Li C, Ueng S . Synovial Fluid Interleukin-16 Contributes to Osteoclast Activation and Bone Loss through the JNK/NFATc1 Signaling Cascade in Patients with Periprosthetic Joint Infection. Int J Mol Sci. 2020; 21(8). PMC: 7215706. DOI: 10.3390/ijms21082904. View

3.
Huang R, Yuan Y, Tu J, Zou G, Li Q . Exaggerated inflammatory environment decreases BMP-2/ACS-induced ectopic bone mass in a rat model: implications for clinical use of BMP-2. Osteoarthritis Cartilage. 2014; 22(8):1186-96. DOI: 10.1016/j.joca.2014.06.017. View

4.
Liu S, Virdi A, Sena K, Hughes W, Sumner D . Bone turnover markers correlate with implant fixation in a rat model using LPS-doped particles to induced implant loosening. J Biomed Mater Res A. 2012; 100(4):918-28. PMC: 3288298. DOI: 10.1002/jbm.a.34029. View

5.
Verdrengh M, Carlsten H, Ohlsson C, Tarkowski A . Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. J Orthop Res. 2006; 25(3):304-10. DOI: 10.1002/jor.20317. View